Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
12 July 2021 |
Main ID: |
ChiCTR1800018340 |
Date of registration:
|
2018-09-12 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Clinical study for cardiac MRI in evaluating early myocardial lesions in patients with muscular dystrophy
|
Scientific title:
|
Clinical study for cardiac MRI in evaluating early myocardial lesions in patients with muscular dystrophy |
Date of first enrolment:
|
2018-09-12 |
Target sample size:
|
Target condition:200;Difficult condition:30 |
Recruitment status: |
Recruiting |
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=29770 |
Study type:
|
Diagnostic test |
Study design:
|
Sequential
|
Phase:
|
0
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Yingkun Guo
|
Address:
|
20 Third Section of Renmin Road South, Wuhou District, Chengdu, Sichuan, China
|
Telephone:
|
+86 18980006572 |
Email:
|
gykpanda@163.com |
Affiliation:
|
Department of Radiology, West China Second Hospital, Sichuan University |
|
Name:
|
Hui Liu
|
Address:
|
20 Third Section of Renmin Road South, Wuhou District, Chengdu, Sichuan, China
|
Telephone:
|
+86 18582548552 |
Email:
|
liuhuiimage@qq.com |
Affiliation:
|
Department of Radiology, West China Second Hospital, Sichuan University |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: patients Diagnosed with muscular dystrophy by genome sequencing, muscle biopsy, and clinically relevant symptoms.
Exclusion criteria: MRI examination contraindications, claustrophobia, contrast allergy, severe renal insufficiency (serum creatinine clearance >120 mmol/L), severe cardiac insufficiency (NYHA-IV grade), frequent atrial fibrillation, thyroid dysfunction.
Age minimum:
4
Age maximum:
18
Gender:
Male
|
Health Condition(s) or Problem(s) studied
|
Muscular dystrophy
|
Intervention(s)
|
Gold Standard:Genomic sequencing, muscle biopsy;Index test:Myocardial strain, T1/T2mapping value, late delayed enhancement (LGE), myocardial first pass perfusion;
|
Primary Outcome(s)
|
Myocardial delayed enhancement;Myocardial tissue stress;Myocardial perfusion;
|
Source(s) of Monetary Support
|
The Ministry of education's new world talent support program
|
Ethics review
|
Status: Approved
Approval date: 28/07/2018
Contact:
Mina
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|